Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account
-
Published:2021-09
Issue:
Volume:295
Page:114202
-
ISSN:0166-0934
-
Container-title:Journal of Virological Methods
-
language:en
-
Short-container-title:Journal of Virological Methods
Author:
Malecki MonikaORCID,
Luesebrink Jessica,
Wendel Andreas F.,
Mattner Frauke
Reference12 articles.
1. Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: experience at a large NHS Foundation Trust in the UK;Colton;J. Infect.,2021
2. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts;Hellewell;Lancet Glob. Health,2020
3. Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2;Iglói;J. Clin. Virol.,2020
4. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards;La Scola;Eur. J. Clin. Microbiol. Infect. Dis.,2020
5. Clinical performance of Roche cobas 6800, Luminex ARIES, MiRXES fortitude kit 2.1, Altona RealStar, and Applied Biosystems TaqPath for SARS-CoV-2 detection in nasopharyngeal swabs;Lee;J. Med. Virol.,2021
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献